Biotech: bubble or investing opportunity?

January 24, 2014

Investing in the biotechnology sector is an exercise in patience and not for the faint of heart because the timelines are long, the risk is high and the reward is far from guaranteed.

But a rise in global IPOs, an increase in invested capital and some noteworthy success stories have made this sector attractive and ripe for investment in the past couple of years – even in Canada, where choked-off credit continues to be a challenge in the sector.

Click here for the article.

Share This Story


“We’re expecting to be somewhere in the area of nine billion people in the next 20 years or so – that’s going to create a lot of pressures on society, and going to create a lot of pressure on our environment. We’re going to have to find new ways to treat people to keep people healthy,” says Andrew Casey, president and CEO of BIOTECanada, the national industry association. “It’s a social imperative that’s leading to a business opportunity.”